Status:

UNKNOWN

Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2

Lead Sponsor:

Intermountain Health Care, Inc.

Conditions:

Critically Ill

Hyperglycemia

Eligibility:

All Genders

1+ years

Phase:

PHASE2

Brief Summary

The Purpose of this study is to: 1. Introduce the refined, validated, and safe computerized bedside decision support tool for blood glucose management in critically ill adult and pediatric ICU patien...

Detailed Description

In the current second phase of this project (Phase-2), we will introduce the refined, validated, and safe eProtocol-insulin into a second group of naïve ICUs, none of which participated in eProtocol-i...

Eligibility Criteria

Inclusion

  • Pediatric ICU: Proposed indications by pediatric clinicians at participating ICUs for glucose control in their ICUs would include patients who require mechanical ventilation for greater than 24 hours and/or require a vasoactive infusion (e.g. dopamine \>3 mg/kg/min, dobutamine, epinephrine, or vasopressin).
  • Adult ICUs: Proposed indications by clinicians in participating ICUs for glucose control in participating adult ICUs include critically ill patients with an anticipated ICU length of stay of 3 or more days.

Exclusion

  • Pregnancy (negative pregnancy test required for females of child-bearing age)
  • Age less than one month
  • Inborn errors of metabolism that the clinician suspects will affect glucose homeostasis
  • Acute or chronic liver disease with any documented episode of blood or plasma glucose \<60 mg/dl within the 24 hours prior to study entry
  • Diabetic Ketoacidosis (critically ill patients with insulin dependent diabetes not in ketoacidosis will be eligible if attending physicians intend to use intravenous insulin as part of ordinary care)
  • Severe chronic liver disease (Child-Pugh score \>10)

Key Trial Info

Start Date :

September 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00654797

Start Date

September 1 2007

End Date

December 1 2018

Last Update

February 26 2015

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Childrens Hospital Centeral California

Madera, California, United States

2

Childrens Hospital of Minnesota - St. Paul

Saint Paul, Minnesota, United States

3

Dartmouth Hitchcock Medical Center

Lebanon, New Hampshire, United States

4

Cornell University Medical College

New York, New York, United States